Five Prime Therapeutics, Inc.: 15-12B filed Apr 26, 2021

Form type

15-12B

Filing date

Apr 26, 2021

Accession number

0001193125-21-131491

Filer

Five Prime Therapeutics, Inc. (CIK 1175505)